Great Point Partners LLC Larimar Therapeutics, Inc. Transaction History

Great Point Partners LLC

  • $216 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
SELL
$4.0 - $6.68 $1.49 Million - $2.5 Million
-373,635 Reduced 29.34%
900,000 $4.08 Million
Q4 2022

Feb 14, 2023
BUY
$2.73 - $5.08 $378,473 - $704,265
138,635 Added 12.21%
1,273,635 $5.26 Million
Q3 2022

Nov 14, 2022
BUY
$1.53 - $3.64 $1.74 Million - $4.13 Million
1,135,000 New
1,135,000 $3.63 Million

Others Institutions Holding LRMR

# of Institutions
127
Shares Held
67.3M
Call Options Held
280K
Put Options Held
76.3K
View Full List

About Larimar Therapeutics, Inc.

LRMR Quotes by TradingView
  • Ticker LRMR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,269,200
  • Market Cap $166M
  • Description
  • Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 1 clinical trial for the treatment of Friedreich's ataxia, a rare, progressive, and fatal genetic disease. T...
More about LRMR
Track This Portfolio

Track Great Point Partners LLC Portfolio

Follow Great Point Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Point Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Great Point Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email